TrialThe journal of headache and pain2026

Long-term safety and effectiveness of rimegepant for the preventive treatment of migraine in Japan: an open-label extension of a phase 3 study.

Yasuhiko Matsumori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.